Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) dropped 4% on Thursday . The company traded as low as $192.50 and last traded at $193.60. Approximately 655,130 shares changed hands during mid-day trading, a decline of 15% from the average daily volume of 766,775 shares. The stock had previously closed at $201.62. Analysts Set […]
LPL Financial LLC raised its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 24.3% during the 1st quarter, HoldingsChannel.com reports. The fund owned 21,398 shares of the medical instruments supplier’s stock after buying an additional 4,185 shares during the period. LPL Financial LLC’s holdings in Insulet were worth $6,825,000 at the end of the […]
Insulet Co. (NASDAQ:PODD – Get Free Report) CEO James Hollingshead bought 5,550 shares of the business’s stock in a transaction that occurred on Monday, August 28th. The shares were acquired at an average price of $181.41 per share, for a total transaction of $1,006,825.50. Following the completion of the transaction, the chief executive officer now […]
Insulet (NASDAQ:PODD – Free Report) had its target price cut by Morgan Stanley from $343.00 to $208.00 in a report published on Thursday morning, MarketBeat Ratings reports. They currently have an equal weight rating on the medical instruments supplier’s stock. Other analysts have also issued research reports about the company. StockNews.com started coverage on Insulet […]
Insulet (NASDAQ:PODD – Free Report) had its price target cut by Bank of America from $365.00 to $295.00 in a research report report published on Thursday, MarketBeat.com reports. They currently have a buy rating on the medical instruments supplier’s stock. Other equities research analysts also recently issued reports about the stock. Raymond James reduced their […]